A Review: Antimicrobial Therapy for Human Pythiosis

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2022 Apr 23

PMID 35453202

Authors

Sadeep Medhasi

Ariya Chindamporn

Navaporn Worasilchai

Affiliations

Soon will be listed here.

Abstract

Human pythiosis is associated with poor prognosis with significant mortality caused by . Antimicrobials' and results against . are inconsistent. Although antimicrobials are clinically useful, they are not likely to achieve therapeutic success alone without surgery and immunotherapy. New therapeutic options are therefore needed. This non-exhaustive review discusses the rationale antimicrobial therapy, minimum inhibitory concentrations, and efficacy of antibacterial and antifungal agents against . This review further provides insight into the immunomodulating effects of antimicrobials that can enhance the immune response to infections. Current data support using antimicrobial combination therapy for the pharmacotherapeutic management of human pythiosis. Also, the success or failure of antimicrobial treatment in human pythiosis might depend on the immunomodulatory effects of drugs. The repurposing of existing drugs is a safe strategy for anti- drug discovery. To improve patient outcomes in pythiosis, we suggest further research and a deeper understanding of virulence factors, host immune response, and host immune system modification by antimicrobials.

Citing Articles

Development of lateral flow immunochromatographic assay with Anti-Pythium insidiosum antibodies for point-of-care testing of vascular pythiosis.

Tongchai P, Burassakarn A, Langsiri N, Worasilchai N, Chindamporn A Sci Rep. 2025; 15(1):781.

PMID: 39755905 PMC: 11700136. DOI: 10.1038/s41598-024-84833-y.

Anti-Pythium insidiosum activity of three novel triazole compounds: synthesis, pharmacokinetic and toxicological parameters.

Fernandes C, Prestes A, Ianiski L, Maciel A, Noro B, da Silva F Braz J Microbiol. 2024; 56(1):331-340.

PMID: 39666162 PMC: 11885195. DOI: 10.1007/s42770-024-01572-y.

Treating Pythiosis with Antibacterial Drugs Targeting Protein Synthesis: An Overview.

Loreto E, Tondolo J, Zanette R J Fungi (Basel). 2024; 10(4).

PMID: 38667905 PMC: 11051233. DOI: 10.3390/jof10040234.

Pythiosis presenting with chronic swelling and painful subcutaneous lesion at right deltoid.

Luangnara A, Chuamanochan M, Chiewchanvit S, Pattamapaspong N, Salee P, Chaiwarith R IDCases. 2023; 33:e01873.

PMID: 37637497 PMC: 10448011. DOI: 10.1016/j.idcr.2023.e01873.

Outcomes of Pythium keratitis: a meta-analysis of individual patient data.

Cao B, Gonugunta V, Radhakrishnan N, Lalitha P, Gurnani B, Kaur K Curr Ophthalmol Rep. 2023; 10(4):198-208.

PMID: 37250102 PMC: 10211475. DOI: 10.1007/s40135-022-00302-7.

References

Permpalung N, Worasilchai N, Manothummetha K, Torvorapanit P, Ratanawongphaibul K, Chuleerarux N . Clinical outcomes in ocular pythiosis patients treated with a combination therapy protocol in Thailand: A prospective study. Med Mycol. 2019; 57(8):923-928. DOI: 10.1093/mmy/myz013. View

Polak A . Preclinical data and mode of action of amorolfine. Clin Exp Dermatol. 1992; 17 Suppl 1:8-12. DOI: 10.1111/j.1365-2230.1992.tb00270.x. View

Cheng Y, Williamson P, Zheng W . Improving therapy of severe infections through drug repurposing of synergistic combinations. Curr Opin Pharmacol. 2019; 48:92-98. PMC: 6858965. DOI: 10.1016/j.coph.2019.07.006. View

Keeratijarut A, Lohnoo T, Rujirawat T, Yingyong W, Kalambaheti T, Miller S . The Immunoreactive Exo-1,3-β-Glucanase from the Pathogenic Oomycete Pythium insidiosum Is Temperature Regulated and Exhibits Glycoside Hydrolase Activity. PLoS One. 2015; 10(8):e0135239. PMC: 4532416. DOI: 10.1371/journal.pone.0135239. View

Majumdar S, Dutta K, Manna S, Basu A, Bishayi B . Possible protective role of chloramphenicol in TSST-1 and coagulase-positive Staphylococcus aureus-induced septic arthritis with altered levels of inflammatory mediators. Inflammation. 2010; 34(4):269-82. DOI: 10.1007/s10753-010-9233-0. View

Mesa-Arango A, Scorzoni L, Zaragoza O . It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug. Front Microbiol. 2012; 3:286. PMC: 3441194. DOI: 10.3389/fmicb.2012.00286. View

Zhang R, Qin X, Kong F, Chen P, Pan G . Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Drug Deliv. 2019; 26(1):328-342. PMC: 6442206. DOI: 10.1080/10717544.2019.1582730. View

Katragkou A, Roilides E, Walsh T . Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces. Clin Infect Dis. 2015; 61 Suppl 6:S622-9. DOI: 10.1093/cid/civ746. View

Tondolo J, Ledur P, Loreto E, Verdi C, Bitencourt P, de Jesus F . Extraction, characterization and biological activity of a (1,3)(1,6)-β-d-glucan from the pathogenic oomycete Pythium insidiosum. Carbohydr Polym. 2016; 157:719-727. DOI: 10.1016/j.carbpol.2016.10.053. View

10.

Itaqui S, Verdi C, Tondolo J, da Luz T, Alves S, Santurio J . In Vitro Synergism between Azithromycin or Terbinafine and Topical Antimicrobial Agents against Pythium insidiosum. Antimicrob Agents Chemother. 2016; 60(8):5023-5. PMC: 4958184. DOI: 10.1128/AAC.00154-16. View

11.

Garrido-Mesa J, Rodriguez-Nogales A, Algieri F, Vezza T, Hidalgo-Garcia L, Garrido-Barros M . Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution. Br J Pharmacol. 2018; 175(23):4353-4370. PMC: 6240124. DOI: 10.1111/bph.14494. View

12.

Bozdogan B, Appelbaum P . Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents. 2004; 23(2):113-9. DOI: 10.1016/j.ijantimicag.2003.11.003. View

13.

Krajaejun T, Imkhieo S, Intaramat A, Ratanabanangkoon K . Development of an immunochromatographic test for rapid serodiagnosis of human pythiosis. Clin Vaccine Immunol. 2009; 16(4):506-9. PMC: 2668273. DOI: 10.1128/CVI.00276-08. View

14.

Sahoo B, Kumar B, Sruti J, Mahapatra M, Banik B, Borah P . Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Front Mol Biosci. 2021; 8:628144. PMC: 7953054. DOI: 10.3389/fmolb.2021.628144. View

15.

Ianiski L, Stibbe P, Denardi L, Weiblen C, Soares M, Valente J . In vitro anti-Pythium insidiosum activity of amorolfine hydrochloride and azithromycin, alone and in combination. Med Mycol. 2020; 59(1):67-73. DOI: 10.1093/mmy/myaa032. View

16.

Lee C, Cho I, Jeong B, Lee S . Strategies to minimize antibiotic resistance. Int J Environ Res Public Health. 2013; 10(9):4274-305. PMC: 3799537. DOI: 10.3390/ijerph10094274. View

17.

Maeno S, Oie Y, Sunada A, Tanibuchi H, Hagiwara S, Makimura K . Successful medical management of keratitis using a combination of minocycline, linezolid, and chloramphenicol. Am J Ophthalmol Case Rep. 2019; 15:100498. PMC: 6593348. DOI: 10.1016/j.ajoc.2019.100498. View

18.

Takahashi G, Sato N, Yaegashi Y, Kojika M, Matsumoto N, Kikkawa T . Effect of linezolid on cytokine production capacity and plasma endotoxin levels in response to lipopolysaccharide stimulation of whole blood. J Infect Chemother. 2010; 16(2):94-9. DOI: 10.1007/s10156-009-0012-5. View

19.

Melida H, Sandoval-Sierra J, Dieguez-Uribeondo J, Bulone V . Analyses of extracellular carbohydrates in oomycetes unveil the existence of three different cell wall types. Eukaryot Cell. 2012; 12(2):194-203. PMC: 3571302. DOI: 10.1128/EC.00288-12. View

20.

Jarrell A, Kruer R, Johnson D, Lipsett P . Antimicrobial Pharmacokinetics and Pharmacodynamics. Surg Infect (Larchmt). 2015; 16(4):375-9. DOI: 10.1089/sur.2014.180. View